This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-123. https://doi.org/10.1007/s12350-019-01760-6.
Longhi S, Quarta CC, Milandri A, Lorenzini M, Gagliardi C, Manuzzi L et al. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid 2015;22:147-55. https://doi.org/10.3109/13506129.2015.1028616.
This work was supported by the Lawson Research Institute, London, Ontario, Canada.
Dr. Cigdem Akincioglu is a consultant for Pfizer. Drs. Rami M. Abazid, Jonathan G. Romsa, James C. Warrington, Robert Z. Stodilka, Ryan A. Davey, Sabe De, David L. Laidley, William C. Vezina, and William C. Vezina have nothing to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Abazid, R.M., Romsa, J.G., Warrington, J.C. et al. Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. J. Nucl. Cardiol. (2021). https://doi.org/10.1007/s12350-020-02508-3